NS1209/SPD 502, A Novel Selective AMPA Antagonist for Stroke, Neuropathic Pain or Epilepsy? Drug Development Lessons Learned
Keppel Hesselink, Jan M.Volume:
78
Language:
english
Journal:
Drug Development Research
DOI:
10.1002/ddr.21376
Date:
March, 2017
File:
PDF, 122 KB
english, 2017